5 May 2015
As part of our commitment to improving the lives of patients, AstraZeneca has teamed up with not-for-profit Sutter Health for a three year research and innovation collaboration, through which we will design, prototype, and pilot innovative approaches to cardiometabolic health care. Cardiometabolic care focuses on the treatment and management of diseases such as diabetes, hypertension and high cholesterol and common, co-occurring serious health complications such as heart attack, stroke, limb loss, blindness and even death.
With improved access and understanding of data, and use of leading-edge technologies, researchers hope to re-engineer the delivery of cardiometabolic care, enabling patients and doctors to spend more time together personalizing care options.
“Diabetes, high blood pressure and poorly controlled cholesterol can have an enormous impact on a person’s quality of life and the cost of health care,” said Greg Keenan, Vice President, Medical Affairs and U.S. Head Medical Officer, AstraZeneca. “We believe that Sutter Health and AstraZeneca will bring together unique expertise and experiences to improve the lives of patients. Through this innovative research collaboration with Sutter Health, we hope to improve the future of cardiometabolic care and translate solutions into programs that health systems nationwide could implement.”
In an effort to help speed diagnosis and improve patients’ quality of life, researchers hope to create forward-looking technologies and treatments through a better understanding of existing gaps in cardiometabolic care.
The collaboration will focus in three key areas.
- Making data meaningful:Researchers will pull key data from across the Sutter Health network into a comprehensive, electronic system and conduct novel, essential analytical steps to continually identify gaps in care; recognize and monitor patient needs; and translate these insights into guideline-based care recommendations.
- Personalizing care: Researchers will design, develop, and implement new tools to help patients and providers work together on care options personalized to a patient’s needs and then develop innovative care approaches for use outside the traditional face-to-face clinic visit.
- Ongoing learning: By tracking the impact of work, researchers will continually grow and evolve their efforts.
More than 29 million people in the United States—or 9.3 percent of the population—have diabetes, for example, estimates the Centers for Disease Control and Prevention (CDC). Adults with diabetes have a 50 percent higher risk of death than those without the disease, and the medical costs for people with diabetes are twice as high as those without. The CDC also estimates 71 million American adults (34 percent) have high LDL-C (bad cholesterol), which puts them at higher risk of developing heart disease. Only 1 out of every 3 adults with high LDL-C has the condition under control. Improvements in cardiometabolic healthcare can potentially improve the health of these patients, reduce complications of these diseases and lower overall healthcare costs.